CN1136878C - Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis - Google Patents
Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis Download PDFInfo
- Publication number
- CN1136878C CN1136878C CNB011040335A CN01104033A CN1136878C CN 1136878 C CN1136878 C CN 1136878C CN B011040335 A CNB011040335 A CN B011040335A CN 01104033 A CN01104033 A CN 01104033A CN 1136878 C CN1136878 C CN 1136878C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- semen
- medicine
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 201000006306 Cor pulmonale Diseases 0.000 title claims abstract description 28
- 210000000582 semen Anatomy 0.000 claims abstract description 40
- 238000002347 injection Methods 0.000 claims abstract description 22
- 239000007924 injection Substances 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000007796 conventional method Methods 0.000 claims abstract description 8
- 208000004186 Pulmonary Heart Disease Diseases 0.000 claims description 25
- 241000208340 Araliaceae Species 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 10
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 241001251068 Formica fusca Species 0.000 claims description 9
- 241000237636 Pheretima Species 0.000 claims description 9
- 235000013351 cheese Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 229960002117 triamcinolone acetonide Drugs 0.000 claims description 6
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 5
- 208000026435 phlegm Diseases 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000241463 Cullen corylifolium Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241001547125 Fritillaria thunbergii Species 0.000 abstract 1
- 241001505523 Gekko gecko Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 241001467552 Mycobacterium bovis BCG Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241001671204 Stemona Species 0.000 abstract 1
- 240000000377 Tussilago farfara Species 0.000 abstract 1
- 235000004869 Tussilago farfara Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 description 19
- 238000002560 therapeutic procedure Methods 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 15
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 206010014561 Emphysema Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000001467 acupuncture Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010006458 Bronchitis chronic Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 208000007451 chronic bronchitis Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000001147 pulmonary artery Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 206010011703 Cyanosis Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 210000004404 adrenal cortex Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000002079 cooperative effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000001951 hemoperfusion Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000031353 Systolic Murmurs Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000026636 chronic pulmonary heart disease Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a medicament for treating cardiopulmonary diseases in catabasis, which comprises traditional Chinese medicine and western medicine. The medicament is characterized in that the traditional Chinese medicine is prepared from tokay gecko, epimedium, Chinese yam, ginseng, ophiopogon root, Chinese magnolivine fruit, stemona root, largehead atractylodes rhizome, sapanwood, cassia twig, poria from Yunnan of China, peach seed, coltsfoot, apricot kernel, heartleaf houttuynia herb, semen, fritillaria thunbergii, prepared liauorice root, raw milkvetch root, earthworm, red sage root, malaytea scurfpea fruit, prepared common monkshood daughter root, rhizoma drynariae and dry ant as raw materials by a conventional method for oral taking, and the traditional Chinese medicine is used cooperatively with the western medicine which comprises phlegm elimination acetonidum A for eliminating phlegm, nucleic junket and Bacillus-Calmette-Guerin vaccination for acupoint injection for jointly treating cardiopulmonary diseases. The present invention has the advantages and the effects of good curative effect, high cure rate, no side effect and low relapse rate.
Description
The present invention relates to the medicine of a cover treatment catabasis pulmonary heart disease, specifically it is to be the Chinese medicine that raw material prepares according to a conventional method with the Chinese herbal medicine, cooperates the medicament of acupoint injection therapy Western medicine therapeutic alliance catabasis pulmonary heart disease again.
Pulmonary heart disease is a chronic bronchitis, bronchial asthma, or the final stage of other pulmonary disease development, mainly be because chronic bronchitis causes the heart disease that pulmonary hypertension caused of lung tissue or pulmonary artery and ramose primary affection thereof, much more comparatively to see in the rural area, sickness rate accounts for about 0.9% around in Beijing, only cause of death investigation statistics shows over 10 years, pulmonary heart disease tops the list in the cause of death of local rural area, at present, the treatment pulmonary heart disease does not have specific drug, most with antiinflammatory, cough-relieving, relieving asthma or with the treatment cardiopathic medicine treat, its effect is undesirable, relapse rate height, mortality rate height.
The objective of the invention is shortcoming and deficiency in order to overcome above-mentioned prior art, and provide a kind of is the Chinese medicine that raw material is made according to a conventional method with the Chinese herbal medicine, cooperate the Western medicine therapeutic alliance catabasis pulmonary heart disease of acupoint injection therapy again, thereby can effectively treat disease, improved cure rate greatly.
The objective of the invention is to realize by following technical proposal:
The medicine of one cover treatment catabasis pulmonary heart disease, it is made up of Chinese medicine and Western medicine, and it is to carry out decocting extraction medicinal liquid according to a conventional method by the following weight proportion raw material to make capsule through concentrate drying powder process to it is characterized in that described Chinese medicine:
Dried Gecko 20-40 part Herba Epimedii 10-20 part Rhizoma Dioscoreae 20-30 part Radix Ginseng 10-15 part
Radix Ophiopogonis 10-15 part Fructus Schisandrae Chinensis 15-20 part Radix Stemonae 15-20 part Rhizoma Atractylodis Macrocephalae 20-30 part
Lignum Sappan 10-15 part Ramulus Cinnamomi 10-15 part Poria 15-20 part Semen Persicae 10-15 part
Flos Farfarae 15-20 part Semen Armeniacae Amarum 10-15 part Herba Houttuyniae 30-40 part Semen Lepidii (Semen Descurainiae) 15-20 part
Bulbus Fritillariae Thunbergii 15-20 part Radix Glycyrrhizae Preparata 10-15 part Radix Astragali 15-20 part Pheretima 10-15 part
Radix Salviae Miltiorrhizae 20-30 part Fructus Psoraleae 15-20 part Radix Aconiti Lateralis Preparata 10-30 part Rhizoma Drynariae 10-20 part
Dried Formica fusca 10-20 part.
Described Western medicine is nuclear cheese and Si Qikang injection.
The excellent weight proportion of making of each raw material of Chinese medicine of the present invention is:
Dried Gecko 25-35 part Herba Epimedii 15-20 part Rhizoma Dioscoreae 20-25 part Radix Ginseng 12-15 part
Radix Ophiopogonis 10-12 part Fructus Schisandrae Chinensis 18-20 part Radix Stemonae 15-18 part Rhizoma Atractylodis Macrocephalae 20-25 part
Lignum Sappan 12-15 part Ramulus Cinnamomi 10-12 part Poria 18-20 part Semen Persicae 10-12 part
Flos Farfarae 15-18 part Semen Armeniacae Amarum 12-15 part Herba Houttuyniae 35-40 part Semen Lepidii (Semen Descurainiae) 18-20 part
Bulbus Fritillariae Thunbergii 15-18 part Radix Glycyrrhizae Preparata 12-15 part Radix Astragali 18-20 part Pheretima 12-15 part
Radix Salviae Miltiorrhizae 20-25 part Fructus Psoraleae 18-20 part Radix Aconiti Lateralis Preparata 15-25 part Rhizoma Drynariae 15-18 part
Dried Formica fusca 15-18 part.
The optimum weight proportioning of each raw material of Chinese medicine of the present invention is:
12 parts of 22 parts of Radix Ginsengs of 18 portions of Rhizoma Dioscoreaes of 30 parts of Herba Epimedii of dried Gecko
22 parts of 18 parts of Rhizoma Atractylodis Macrocephalaes of 18 parts of Radixs Stemonae of 12 parts of Fructus Schisandrae Chinensis Radix Ophiopogonis
10 parts in 20 parts of Semen Persicaes of 12 parts of Poria of 12 parts of Ramulus Cinnamomi of Lignum Sappan
18 parts of 35 parts of Semen Lepidii (Semen Descurainiae)s of 12 parts of Herba Houttuyniae of 15 parts of Semen Armeniacae Amarums of Flos Farfarae
12 parts of 18 parts of Pheretimas of 12 parts of Radix Astragali of 15 parts of Radix Glycyrrhizae Preparatas of Bulbus Fritillariae Thunbergii
15 parts of 20 parts of Rhizoma Drynariae of 18 parts of Radix Aconiti Lateralis Preparatas of 20 parts of Fructus Psoraleae of Radix Salviae Miltiorrhizae
15 parts of dried Formica fuscas.
Owing to during the pulmonary heart disease acute attack that bronchial asthma causes, increase the Triamcinolone Acetonide acupoint injection therapy again.
Patients with cor pulmonale, owing to show effect and long-term severe depletion of oxygen repeatedly, repeated infection, lung tissue is blood stasis in various degree, and of a specified duration can cause adrenal cortex secretion wretched insufficiency, the normal person secretes hydrocortisone 25mg every day, secrete 250mg in case of necessity, when functional disorder, acth secretion seriously reduces, general weakness can appear, the waist lower limb is soft, the resisting cold ability is very low, mucocutaneous pigment is felt.The whole body cyanosis, modern medicine study thinks that pulmonary heart disease has the serious low evidence of hypophysis-adrenal cortex function, respectively organize severe depletion of oxygen, confirm that through literature survey research and pharmacological research kidney-reinforcing drug can improve this function, illustrates that the kidney invigorating therapy meets modern medical theory, through for many years clinical practice proof its by increasing effect of adrenal cortex function, promote the body cell metabolism, improve the low situation of body's immunity, improve the nonspecific defense function of body, can resist the change and the extraneous infective agent of weather, pathological change is developed towards the direction that helps the body reparation, and by the expansible blood vessel of removing blood stasis blood medicine, logical blood flow relaxes, microcirculation improvement, increase lung tissue hemoperfusion amount, improve pathological change, pass through acupoint injection therapy again, stimulating acupoint is brought about the desired sensation, dredging the meridian, QI and blood, negative and positive are regulated internal organs, therapy of combining Chinese and Western medicine, specimen is held concurrently solid, the performance cooperative effect is improved the heart, lung, renal function promotes early recovery.
Chinese medicine preparation of the present invention is according to theory of Chinese medical science, in conjunction with for many years clinical practice and the result who sums up.
Wherein: Radix Ginseng, Radix Ophiopogonis, Fructus Schisandrae Chinensis, the Rhizoma Atractylodis Macrocephalae, Lignum Sappan, Ramulus Cinnamomi, Radix Astragali, Radix Salviae Miltiorrhizae, Radix Aconiti Lateralis Preparata are monarch drug; Dried Gecko, Herba Epimedii, Rhizoma Dioscoreae are ministerial drug; Semen Armeniacae Amarum, Herba Houttuyniae, Semen Lepidii (Semen Descurainiae) are adjuvant drug; All the other are messenger drug.
Chinese medicine of the present invention has the kidney invigorating lung benefiting, hold concurrently solid heart spleen, cough-relieving, really expectorant, antiinflammatory, the adjusting equilibrium between yin and yang of relievining asthma, compensate qi and blood, and removing blood stasis is invigorated blood circulation, blood vessel dilating, the logical blood flow that relaxes, microcirculation improvement, increase lung tissue hemoperfusion amount, increase immunologic function, make it to cure.
Acupoint injection therapy, conventional acupoint selection are Dingchuan, Danzhong, feishu, canopy, Xinshu, Shenshu, the concurrent infection abundant expectoration: Tiantu, foot three reasons.
The pulmonary heart disease Western medicine injection acupuncture point that bronchial asthma causes: Shenshu, Xinshu.
The acupuncture point effect:
DINGCHUAN acupoint: can relieving asthma and cough, lung qi dispersing is regulated the flow of vital energy; Point cv 20: the energy resolving phlegm and relieving asthma, the sending down the abnormal ascending QI cough-relieving, the internal organs of having a strong smell are the positions of internal organs through the gas infusion, TIANTU acupoint is that acupoints on Ren channel potential energy lung qi dispersing is had one's ideas straightened out sore-throat relieving eliminating stagnation, eliminating phlegm and lowering adverse QI.Equilibrium between yin and yang is regulated in the tsu san li the kidney invigorating, and all caves cooperate injection to play the effect of lowering the adverse-rising QI to subdue asthma expectorant altogether.
The Western medicine Triamcinolone Acetonide is a hormone medicine, is used for acute attack, has antiinflammatory, anti-allergic effects, effectively controlling symptoms.Si Qikang and nuclear cheese can improve the immunity of body, prevent flu.
By the acupoint injection therapy Western medicine, the meridian dredging that can relax increases curative effect of medication, regulates zang-fu disharmony, and Yin Yang balancing increases immunologic function, plays the effect of acupuncture.Function is regulated in the Chinese and Western combination, and the human body immunity improving function increases resistance against diseases, improves lung, spleen, renal function, reaches the purpose of healthy recovery from illness.
Clinical test results:
One, clinical data:
1000 examples are organized in treatment, male 600 examples, and women 400 examples, the age, the course of disease is the longest 60 years, and was the shortest 5 years in 30-70 year, merged coronary heart disease 320 examples, emphysema 50 examples.
Two, diagnosis basis:
1, there are chronic bronchitis, bronchial asthma, emphysema and other to cause the structure of lung or functional lesion and cause the disease of hypertrophy of right heart.
2, symptom and sign: chronic cough, excessive phlegm symptom and emphysema sign are arranged, there are enhanced systole pollex and/or TA hear sounds obviously to strengthen under the xiphoid-process or systolic murmur occurs, second sound of pulmonary area is obviously hyperfunction, cardiopalmus occurs in acute respiratory infection or after, breathe hard and symptom such as cyanosis and right merit aroused in interest are not all levied than aggravating activities.
3, chest x-ray diagnosis:
(1) arteriosus truncus expansion: transverse diameter 〉=1.5cm under the right lung, the broadening of arteriosus truncus transverse diameter reaches more than the 2mm under the right lung through dynamic observing;
(2), pulmonary artery protrudes, highly 〉=3mm;
(3), center pulmonary artery expansion and periphery branch very thin both form sharp contrast, be " undesirable root shape ";
(4), diaphram descends adhesion;
(5) the narrow shape heart;
(6) right ventricle increases;
Have (1)-(5) in more than two or (6) item person diagnosable.
4, Electrocardioscopy:
(1) axle right avertence;
(2) repeat clockwise rotation;
(3) P of pulmonary ripple.
Three, Therapeutic Method:
Patient's oral Chinese medicine, day clothes 3 times, serve on 6 months by each 8.
Acupoint injection therapy: Si Qikang and nuclear cheese, consumption 2ml, injection in per three days once exchanged Western medicine and injects in per three days.
Acupuncture point: feishu, Dingchuan, canopy, Xinshu, Shenshu, Danzhong, Tiantu, tsu san li.
Cooperate cytochrome C, each 30mg and 25% glucose intravenous injection, glycosuria patient use normal saline, twice of every day.
Because during the pulmonary heart disease acute attack that bronchial asthma causes, increase Shenshu, the Xinshu acupoint injection therapy scorching relaxed and comfortable A that dispels, per three days are once, each 2ml.
Four, treatment time: the catabasis after the acute attack control.
Five, treatment standard:
Chronic pulmonary heart disease illness analysis and curative effect judging standard according to whole nation pulmonary heart disease specialized conference formulation for the second time in 1977.
Six, therapeutic outcome:
Each age group patients with cor pulmonale therapeutic outcome
Age 30-40 year 41-60 year is more than 61 years old
Total example several 30 50 270 130 300 220
Sex men and women men and women men and women
Cure 82 34 12 56 25
Take a turn for the better 20 42 208 106 204 160
Invalid 26 28 12 40 35
Cure rate 12.5% 11.5% 15.57%
Improvement rate 77.5% 78.5% 70%
Inefficiency 10% 10% 14.43%
Model case:
Yan, the man, 76 years old, the Cantonese suffered from bronchial asthma 36 years, breathed hard, and dyspnea 20 years increased the weight of 16 years, once at regional hospital admissions such as Guangzhou, Beijing, was diagnosed as bronchial asthma, emphysema, pulmonary heart disease, unsatisfactory curative effect.Transfer me and institute go to a doctor, through the treatment of three courses of treatment, symptom all disappears, the rabat prompting, and heart is normal substantially, and the lung inflation amount disappears; Electrocardiogram is normal; Vital capacity is increased to 2850ml by 1000ml.So far 5 years are not complicated, and engage in trade in the city.
The king so-and-so, the man, 60 years old, the Pekinese suffered from bronchial asthma 30 years, increase the weight of year by year, uncomfortable in chest during outbreak, breathe hard, breathe and be the devil, moving then breathe heavily, once merge coronary heart disease treatment with asthma, emphysema, pulmonary heart disease in how tame hospitals such as Beijing Hospital, Army Hospitals, effect is all not obvious, introduces me institute to go to a doctor through friend.Through two course of therapy, symptom all disappears, and two diaphragm range of activity are normal, and hypertrophy of right heart disappears, and electrocardiogram is normal, and vital capacity is increased to 2700ml by 500ml, so far not recurrence.
Tang so-and-so, the man, 70 years old, people from Tong County, the chronic discontinuity cough with asthma of patient was panted 46 years, with cardiopalmus, breathe hard, dyspnea, moving then increase the weight of, once to Beijing, Tong County hospital seeks medical advice in many ways and do not feel any better.Come electrograph normal, vital capacity is increased to 2700ml by 500ml, so far not recurrence.
Tang so-and-so, the man, 70 years old, people from Tong County, the chronic discontinuity cough with asthma of patient was panted 46 years, with cardiopalmus, breathe hard, dyspnea, moving then increase the weight of, once to Beijing, Tong County hospital seeks medical advice in many ways and do not feel any better.Come me institute to go to a doctor, through three course of therapy, symptom all disappears, edema of pair of lower extremities disappears, heart circle is carried on lung voiced sound circle near normal, rabat prompting: carry on the diaphram, lung marking is slightly thick, podiod is roughly normal, and electrocardiogram, electric axis are not inclined to one side, no transposition, and vital capacity is increased to 2700ml by 1500ml, can participate in normal work, so far not recurrence.
Owing to adopt technique scheme, make the technology of the present invention compared with the prior art have following advantage and effect:
A) adopt the integrative therapy pulmonary heart disease to recover adrenocortical function by Chinese medicine, the human body immunity improving ability reaches the specimen hair strengthening of holding concurrently by acupoint injection therapy again and waves cooperative effect, promotes early recovery;
B), prescription is scientific and reasonable, preparation method is simple;
C), therapeutic effect is good, cure rate height, no side effects.
Embodiment 1:
Get dried Gecko 30g, Herba Epimedii 18g, Rhizoma Dioscoreae 22g, Radix Ginseng 12g, Radix Ophiopogonis 12g, Fructus Schisandrae Chinensis 18g, Radix Stemonae 18g, Rhizoma Atractylodis Macrocephalae 22g, Lignum Sappan 12g, Ramulus Cinnamomi 12g, Poria 20g, Semen Persicae 10g, Flos Farfarae 15g, Semen Armeniacae Amarum 12g, Herba Houttuyniae 35g, Semen Lepidii (Semen Descurainiae) 18g, Bulbus Fritillariae Thunbergii 15g, Radix Glycyrrhizae Preparata 12g, Radix Astragali 18g, Pheretima 12g, Radix Salviae Miltiorrhizae 20g, Fructus Psoraleae 18g, Radix Aconiti Lateralis Preparata 20g, Rhizoma Drynariae 15g, carry out decocting after 15 parts of mixing of dried Formica fusca according to a conventional method and extract medicinal liquid,, make capsule through concentrate drying powder process, every 0.5g is product through being up to the standards.
Cooperate Western medicine acupoint injection therapy nuclear cheese and Si Qikang during treatment, the pulmonary heart disease injection Triamcinolone Acetonide that bronchial asthma causes.
Embodiment 2:
Get dried Gecko 20g, Herba Epimedii 20g, Rhizoma Dioscoreae 20g, Radix Ginseng 15g, Radix Ophiopogonis 10g, Fructus Schisandrae Chinensis 20g, Radix Stemonae 15g, Rhizoma Atractylodis Macrocephalae 30g, Lignum Sappan 10g, Ramulus Cinnamomi 15g, Poria 15g, Semen Persicae 12g, Flos Farfarae 18g, Semen Armeniacae Amarum 10g, Herba Houttuyniae 40g, Semen Lepidii (Semen Descurainiae) 15g, Bulbus Fritillariae Thunbergii 20g, Radix Glycyrrhizae Preparata 10g, Radix Astragali 15g, Pheretima 10g, Radix Salviae Miltiorrhizae 30g, Fructus Psoraleae 15g, Radix Aconiti Lateralis Preparata 30g, Rhizoma Drynariae 10g, carry out decocting after 10 parts of mixing of dried Formica fusca according to a conventional method and extract medicinal liquid,, make capsule through concentrate drying powder process, every 0.5g is product through being up to the standards.
Cooperate Western medicine acupoint injection therapy nuclear cheese and Si Qikang during treatment, the pulmonary heart disease injection Triamcinolone Acetonide that bronchial asthma causes.
Embodiment 3:
Get dried Gecko 40g, Herba Epimedii 10g, Rhizoma Dioscoreae 30g, Radix Ginseng 10g, Radix Ophiopogonis 15g, Fructus Schisandrae Chinensis 15g, Radix Stemonae 20g, Rhizoma Atractylodis Macrocephalae 20g, Lignum Sappan 15g, Ramulus Cinnamomi 10g, Poria 18g, Semen Persicae 15g, Flos Farfarae 20g, Semen Armeniacae Amarum 15g, Herba Houttuyniae 30g, Semen Lepidii (Semen Descurainiae) 20g, Bulbus Fritillariae Thunbergii 18g, Radix Glycyrrhizae Preparata 15g, Radix Astragali 20g, Pheretima 15g, Radix Salviae Miltiorrhizae 25g, Fructus Psoraleae 20g, Radix Aconiti Lateralis Preparata 10g, Rhizoma Drynariae 20g, carry out decocting after 20 parts of mixing of dried Formica fusca according to a conventional method and extract medicinal liquid,, make capsule through concentrate drying powder process, every 0.5g is product through being up to the standards.
Cooperate Western medicine acupoint injection therapy nuclear cheese and Si Qikang during treatment, the pulmonary heart disease injection Triamcinolone Acetonide that bronchial asthma causes.
Claims (4)
1, the medicine of a cover treatment catabasis pulmonary heart disease, it is made up of Chinese medicine and Western medicine, and it is to carry out decocting according to a conventional method by the following weight proportion raw material to extract the capsule that medicinal liquid is made through concentrate drying powder process to it is characterized in that described Chinese medicine:
Dried Gecko 20-40 part Herba Epimedii 10-20 part Rhizoma Dioscoreae 20-30 part Radix Ginseng 10-15 part
Radix Ophiopogonis 10-15 part Fructus Schisandrae Chinensis 15-20 part Radix Stemonae 15-20 part Rhizoma Atractylodis Macrocephalae 20-30 part
Lignum Sappan 10-15 part Ramulus Cinnamomi 10-15 part Poria 15-20 part Semen Persicae 10-15 part
Flos Farfarae 15-20 part Semen Armeniacae Amarum 10-15 part Herba Houttuyniae 30-40 part Semen Lepidii (Semen Descurainiae) 15-20 part
Bulbus Fritillariae Thunbergii 15-20 part Radix Glycyrrhizae Preparata 10-15 part Radix Astragali 15-20 part Pheretima 10-15 part
Radix Salviae Miltiorrhizae 20-30 part Fructus Psoraleae 15-20 part Radix Aconiti Lateralis Preparata 10-30 part Rhizoma Drynariae 10-20 part
Dried Formica fusca 10-20 part.
Described Western medicine is nuclear cheese and Si Qikang injection.
2, the medicine of a cover treatment pulmonary heart disease according to claim 1 is characterized in that the weight proportion of described each raw material of Chinese medicine is:
Dried Gecko 25-35 part Herba Epimedii 15-20 part Rhizoma Dioscoreae 20-25 part Radix Ginseng 12-15 part
Radix Ophiopogonis 10-12 part Fructus Schisandrae Chinensis 18-20 part Radix Stemonae 15-18 part Rhizoma Atractylodis Macrocephalae 20-25 part
Lignum Sappan 12-15 part Ramulus Cinnamomi 10-12 part Poria 18-20 part Semen Persicae 10-12 part
Flos Farfarae 15-18 part Semen Armeniacae Amarum 12-15 part Herba Houttuyniae 35-40 part Semen Lepidii (Semen Descurainiae) 18-20 part
Bulbus Fritillariae Thunbergii 15-18 part Radix Glycyrrhizae Preparata 12-15 part Radix Astragali 18-20 part Pheretima 12-15 part
Radix Salviae Miltiorrhizae 20-25 part Fructus Psoraleae 18-20 part Radix Aconiti Lateralis Preparata 15-25 part Rhizoma Drynariae 15-18 part
Dried Formica fusca 15-18 part.
3, the medicine of a cover treatment pulmonary heart disease according to claim 1 is characterized in that the weight proportion of described each raw material of Chinese medicine is:
12 parts of 22 parts of Radix Ginsengs of 18 portions of Rhizoma Dioscoreaes of 30 parts of Herba Epimedii of dried Gecko
22 parts of 18 parts of Rhizoma Atractylodis Macrocephalaes of 18 parts of Radixs Stemonae of 12 parts of Fructus Schisandrae Chinensis Radix Ophiopogonis
10 parts in 20 parts of Semen Persicaes of 12 parts of Poria of 12 parts of Ramulus Cinnamomi of Lignum Sappan
18 parts of 35 parts of Semen Lepidii (Semen Descurainiae)s of 12 parts of Herba Houttuyniae of 15 parts of Semen Armeniacae Amarums of Flos Farfarae
12 parts of 18 parts of Pheretimas of 12 parts of Radix Astragali of 15 parts of Radix Glycyrrhizae Preparatas of Bulbus Fritillariae Thunbergii
15 parts of 20 parts of Rhizoma Drynariae of 18 parts of Radix Aconiti Lateralis Preparatas of 20 parts of Fructus Psoraleae of Radix Salviae Miltiorrhizae
15 parts of dried Formica fuscas.
4, the medicine of a cover treatment pulmonary heart disease according to claim 1 is characterized in that described Western medicine also has the Triamcinolone Acetonide injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011040335A CN1136878C (en) | 2001-02-19 | 2001-02-19 | Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011040335A CN1136878C (en) | 2001-02-19 | 2001-02-19 | Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1310000A CN1310000A (en) | 2001-08-29 |
| CN1136878C true CN1136878C (en) | 2004-02-04 |
Family
ID=4653632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011040335A Expired - Fee Related CN1136878C (en) | 2001-02-19 | 2001-02-19 | Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1136878C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441129B (en) * | 2011-12-02 | 2013-07-17 | 香河县气管炎哮喘医院 | Traditional Chinese medicine for treating chronic pulmonary heart disease |
| CN103169905B (en) * | 2012-03-31 | 2014-04-30 | 陈欣 | Traditional Chinese medicine capsule preparation for treating lung-heart disease and preparation method thereof |
| CN103169907B (en) * | 2012-03-31 | 2014-06-18 | 毕玉珍 | Traditional Chinese medicine tablet preparation for treating lung-heart disease and preparation method thereof |
| CN103169906B (en) * | 2012-03-31 | 2014-06-18 | 李风芹 | Traditional Chinese medicine powder preparation for treating lung-heart disease and preparation method thereof |
| CN105147744A (en) * | 2015-10-29 | 2015-12-16 | 北京岐黄制药有限公司 | Drynaria and its extracts for preventing or treating cor pulmonale |
-
2001
- 2001-02-19 CN CNB011040335A patent/CN1136878C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1310000A (en) | 2001-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526674A (en) | Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven | |
| CN102552773A (en) | Drug for treating bronchitis and bronchial asthma of 7-15 year old children | |
| CN1167454C (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN1970069B (en) | Chinese medicinal pill for treating coronary heart disease | |
| CN1136878C (en) | Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis | |
| CN104208643B (en) | It is a kind of to treat Chinese medicine of hemiplegia and preparation method thereof | |
| CN102283956A (en) | Orally administered drug for treating chronic hepatitis | |
| CN1840006A (en) | Medicine for treating aplastic anemia | |
| CN1136880C (en) | Combined Chinese and Western medicine for treating bronchial asthma | |
| CN1136881C (en) | Combined Chinese and Western medicine for treating pulmonary emphysema | |
| CN1136879C (en) | Combined Chinese and Western medicine for treating chronic bronchitis in catabasis | |
| CN100493586C (en) | Oral liquid for treating breast cancer, liver cancer or lung cancer and production method thereof | |
| CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
| CN103536849A (en) | Drug for treating pulmonary embolism and preparation method thereof | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
| CN105106508A (en) | Cocklebur fruit allergic rhinitis paste | |
| CN1051018C (en) | Health bag for stomach and kidney | |
| CN1857510A (en) | Medicine for treating coronary heart disease | |
| CN105311222A (en) | Traditional Chinese medicine composition for treating chronic heart failure | |
| CN105853635A (en) | Pharmaceutical composition for treating angina pectoris of coronary heart disease | |
| CN105535852A (en) | Traditional Chinese medicine preparation for treating arrhythmia | |
| CN105327045A (en) | Lipid-lowering traditional Chinese medicine for treating NAFLD (non-alcoholic fatty liver diseases) and treatment method | |
| CN1679663A (en) | Capsules for nourishing kidney and relaxing bowels and their production | |
| CN104027571A (en) | Traditional Chinese medicine composition for treating chronic pulmonary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040204 Termination date: 20190219 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |